Susceptibility of turkeys to pandemic-H1N1 virus by reproductive tract insemination
© Pantin-Jackwood et al; licensee BioMed Central Ltd. 2010
Received: 18 December 2009
Accepted: 3 February 2010
Published: 3 February 2010
The current pandemic influenza A H1N1 2009 (pH1N1) was first recognized in humans with acute respiratory diseases in April 2009 in Mexico, in swine in Canada in June, 2009 with respiratory disease, and in turkeys in Chile in June 2009 with a severe drop in egg production. Several experimental studies attempted to reproduce the disease in turkeys, but failed to produce respiratory infection in turkeys using standard inoculation routes. We demonstrated that pH1N1 virus can infect the reproductive tract of turkey hens after experimental intrauterine inoculation, causing decreased egg production. This route of exposure is realistic in modern turkey production because turkey hens are handled once a week for intrauterine insemination in order to produce fertile eggs. This understanding of virus exposure provides an improved understanding of the pathogenesis of the disease and can improve poultry husbandry to prevent disease outbreaks.
Because of the known susceptibility of turkeys to type A influenza viruses and the history of infection with triple reassortant viruses [1–6], when the pandemic influenza A H1N1 2009 (pH1N1) emerged, the possibility of turkeys becoming infected with the novel virus was investigated. However, experimental challenge with pH1N1 virus by the respiratory route showed that both turkey poults and adult turkey hens were resistant to infection [7–9], but infection was produced in young turkeys by the novel intracloacal route of inoculation (J. Pasick, personal communication). In August 2009, pH1N1 virus was detected in two turkey breeder farms in Chile presenting drops in egg production . Epidemiological investigations on the possible source of infection identified workers with respiratory problems, and hen insemination as a risk factor for virus transmission to the birds. A second and third outbreak in turkey hens occurred in Canada, in September 2009, and in the USA, in November 2009, with a marked drop in egg production as the primary clinical sign of disease [11, 12]. These three outbreaks of pH1N1 influenza in turkeys raised the question of how the turkey hens became infected when experimental evidence suggested that turkeys were refractory to respiratory infection.
In our previous study, 73-week-old turkey hens and 3-week-old turkey poults were intranasally inoculated with A/Mexico/4108/09 (H1N1) . None of the turkeys developed clinical signs or died, no virus was detected in tissues, and all turkeys were negative for antibodies to the virus, indicating that they did not become infected. In another study, 21- and 70-day-old meat turkeys were oro-nasally inoculated with A/Italy/2810/2009 (H1N1) influenza virus. Virus was not recovered by molecular or conventional methods from blood, tracheal and cloacal swabs, lungs, intestine or muscle tissue, and only some birds seroconverted . In a third study, inoculation of 3-week-old turkeys with A/CA/07/09 (H1N1) through the intranasal and intraocular route also failed to initiate infection .
In order to understand how the pH1N1 virus potentially had infected turkey breeders, we conducted a study in which we inoculated 53-week-old laying turkey hens with 105.3 50% cell culture infective doses of A/Chile/3536/2009 (H1N1) virus by three different routes. Eight hens were inoculated intranasally (IN), four hens were inoculated intracloacally (IC), and four hens were inoculated through the intrauterine (IU) route. Oropharyngeal and cloacal swabs were taken from all hens at days 2, 4, 7, 10, and 14 days post-inoculation (dpi), and lung, spleen, heart, kidney and oviduct were taken from one hen per group at 3 and 7 dpi for virus detection by quantitative real-time reverse transcriptase polymerase chain reaction (qRRT-PCR) assay targeted to the influenza virus matrix gene with the described modified reverse primer 3'-cagagactggaaagtgtctttgca-5' [8, 13]. Tissues were also taken for histology and viral antigen detection by immunohistochemistry (IHC). For IHC, mouse monoclonal antibody P13C11, specific for influenza A nucleoprotein, was used. Sections were stained as previously described . Serum was collected from the remaining turkeys at the end of the 14-day study for antibody testing by hemagglutination inhibition (HI).
Results of qRRT-PCR testing for pH1N1 virus in oropharyngeal and cloacal swabs of experimental turkey hens inoculated intranasally, intracloacally, or intrauterine with A/Chile/3536/2009 (H1N1) virus.
Sampling day (days post inoculation) for swabs
In this study, and consistent with previous studies, turkeys IN-inoculated with the pH1N1 influenza virus did not become infected with the virus, although the respiratory route is considered the natural route of exposure for influenza A viruses in many animal species. However, IC or IU-inoculation with the virus resulted in pH1N1 virus infection. Such routes of exposure are realistic in modern turkey production because turkey hens are handled once a week for insemination, which deposits semen into the uterus, in order to produce fertile eggs, because modern tom turkeys are physically unable to efficiently breed naturally because of their large breast muscles. During this process, workers handle individual hens, manually everting the cloaca to locate the vagina for insertion of the insemination straw. Because of the close contact with infected humans, this routine insemination activity provided opportunity for initiating the infection process by either large droplet exposure during human sneezing activities or direct inoculation from infectious fomites on contaminated hands, and bird-to-bird transmission through mechanical fomite inoculation to the cloaca or reproductive tract by the inseminators. This is the first study to show infection by intrauterine exposure to influenza A virus in turkeys and such transmission is consistent with the proposed risk of infected insemination crews in cases of pH1N1 in Chilean turkey hens . However, replication and shedding from the respiratory tract following IU-inoculation is perplexing considering IN-inoculation failed to produce infection. Possibly, the IU-inoculation and infection resulted in changes in the virus that allowed subsequent respiratory infection. Future studies will examine such viruses recovered from respiratory tract for changes in viral tissue tropism.
influenza A H1N1 2009
quantitative real-time reverse transcriptase polymerase chain reaction
This research was supported by USDA Current Research Information Systems project 6612-32000-048-00D. Joan R. Beck, James Doster, Kira Moresco, Diane Smith, Caran Cagle, and Scott Lee provided technical assistance. Dr. Alexander Klimov at the Centers for Disease Control and Prevention, and the Chilean Public Health Laboratory are thanked for providing the challenge virus.
- Choi YK, Lee JH, Erickson G, Goyal SM, Joo HS, Webster RG, Webby RJ: H3N2 influenza virus transmission from swine to turkeys, United States. Emerg Infect Dis 2004, 10: 2156-2160.PubMedPubMed CentralView Article
- Kapczynski DR, Gonder E, Liljebjelke K, Lippert R, Petkov D, Tilley B: Vaccine-induced protection from egg production losses in commercial turkey breeder hens following experimental challenge with a triple-reassortant H3N2 avian influenza virus. Avian Dis 2009, 53: 7-15. 10.1637/8199-122707-Reg.1PubMedView Article
- Pillai SPS, Pantin-Jackwood M, Jadhao SJ, Suarez DL, Wan L, Yassine M, Saif M, Lee CW: Pathobiology of triple reassortant H3N2 influenza viruses in breeder turkeys and its potential implication for vaccine studies in turkeys. Vaccine 2009, 27: 819-824. 10.1016/j.vaccine.2008.11.076PubMedView Article
- Senne DA: Avian Influenza in North and South America, the Caribbean, and Australia 2006-2008. Avian Dis 2010, in press.
- Yassine HM, Al Natour MQ, Lee C, Saif YM: Interspecies and intraspecies transmission of triple reassortant H3N2 influenza A viruses. Virol J 2007, 4: 129. 10.1186/1743-422X-4-129PubMedPubMed CentralView Article
- Suarez DL, Woolcock PR, Bermudez AJ, Senne DA: Isolation from turkey breeder hens of a reassortant H1N2 influenza virus with swine, human, and avian lineage genes. Avian Dis 2002, 46: 111-121. 10.1637/0005-2086(2002)046[0111:IFTBHO]2.0.CO;2PubMedView Article
- Russell C, Hanna A, Barrass L, Matrosovich M, Nunez A, Brown IH, Choudhury B, Banks J: Experimental infection of turkeys with pandemic (H1N1) 2009 influenza virus (A/H1N1/09v). J Virol 2009, 83: 13046-13047. 10.1128/JVI.01645-09PubMedPubMed CentralView Article
- Swayne DE, Pantin-Jackwood M, Kapczynski D, Spackman E, Suarez DL: Susceptibility of poultry to pandemic (H1N1) 2009 Virus. Emerg Infect Dis 2009, 15: 2061-2063. 10.3201/eid1512.091060PubMedPubMed CentralView Article
- Terregino C, De NR, Nisi R, Cilloni F, Salviato A, Fasolato M, Capua I: Resistance of turkeys to experimental infection with an early 2009 Italian human influenza A(H1N1)v virus isolate. Euro Surveill 2009, 14: 19360.PubMed
- Influenza A H1N1, Chile[http://www.oie.int/wahis/public.php?page=single_reportpop=1reportid=8389]
- Pandemic H1N1 2009, Canada[http://www.oie.int/wahis/public.php?page=single_reportpop=1reportid=8578]
- 2009 pandemic A/H1N1 influenza virus, United States of America[http://www.oie.int/wahis/public.php?page=single_reportpop=1reportid=8709]
- Spackman E, Senne DA, Myers TJ, Bulaga LL, Garber LP, Perdue ML, Lohman K, Daum LT, Suarez DL: Development of a real-time reverse transcriptase PCR assay for type A influenza virus and the avian H5 and H7 hemagglutinin subtypes. J Clin Microbiol 2002, 40: 3256-3260. 10.1128/JCM.40.9.3256-3260.2002PubMedPubMed CentralView Article
- Perkins LEL, Swayne DE: Pathobiology of A/chicken/Hong Kong/220/97 (H5N1) avian influenza virus in seven gallinaceous species. Vet Pathol 2001, 38: 149-164. 10.1354/vp.38-2-149PubMedView Article
- Lee CW, Suarez DL: Application of real-time RT-PCR for the quantitation and competitive replication study of H5 and H7 subtype avian influenza virus. Journal of Virological Methods 2004, 119: 151-158. 10.1016/j.jviromet.2004.03.014PubMedView Article
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.